Pfizer antiviral drug could nearly end deaths from COVID-19, company study suggests

Posted on AllSides November 5th, 2021
From The Left
Merck & Co./USA Today

A new drug being developed by Pfizer offers the possibility of nearly putting an end to deaths from COVID-19.

When given within five days of the onset of symptoms, the antiviral therapy called Paxlovid, prevented almost 90% of deaths from COVID-19 compared to a placebo, a Pfizer study found.

By the end of the year, the company plans to complete two other studies of the pill, which is given twice a day for five days. Pfizer plans to submit the study data as part of its ongoing rolling submission to the Food and...

Read full story
Some content from this outlet may be limited or behind a paywall.


AllSides Media Bias Rating: Lean Left
AllSides Media Bias Rating: Lean Left
See full bias rating for USA TODAY
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right